Aberdeen Group plc Has $41.77 Million Stake in Merit Medical Systems, Inc. $MMSI

Aberdeen Group plc reduced its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 8.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 473,895 shares of the medical instruments supplier’s stock after selling 44,768 shares during the quarter. Aberdeen Group plc owned 0.80% of Merit Medical Systems worth $41,769,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Tudor Investment Corp ET AL acquired a new position in Merit Medical Systems during the third quarter valued at $2,913,050,000. Wellington Management Group LLP grew its stake in Merit Medical Systems by 377.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after acquiring an additional 980,823 shares in the last quarter. Norges Bank purchased a new position in Merit Medical Systems during the 2nd quarter valued at about $53,697,000. Thrivent Financial for Lutherans increased its holdings in shares of Merit Medical Systems by 250.5% in the 3rd quarter. Thrivent Financial for Lutherans now owns 750,066 shares of the medical instruments supplier’s stock valued at $62,428,000 after purchasing an additional 536,072 shares during the period. Finally, Greenhouse Funds LLLP increased its holdings in shares of Merit Medical Systems by 48.3% in the 3rd quarter. Greenhouse Funds LLLP now owns 871,927 shares of the medical instruments supplier’s stock valued at $72,570,000 after purchasing an additional 284,015 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on MMSI shares. Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Barrington Research upped their price objective on shares of Merit Medical Systems from $106.00 to $109.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. BTIG Research started coverage on shares of Merit Medical Systems in a research note on Friday, February 6th. They set a “buy” rating and a $107.00 target price for the company. Needham & Company LLC restated a “buy” rating and set a $101.00 price target on shares of Merit Medical Systems in a report on Wednesday. Finally, Robert W. Baird set a $108.00 price target on shares of Merit Medical Systems in a research note on Tuesday, December 16th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $101.25.

Merit Medical Systems Stock Performance

MMSI stock opened at $67.70 on Friday. The firm has a 50 day moving average of $75.42 and a two-hundred day moving average of $81.59. Merit Medical Systems, Inc. has a 12 month low of $66.34 and a 12 month high of $106.11. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of 31.93, a P/E/G ratio of 1.95 and a beta of 0.64. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. The business had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. Merit Medical Systems’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, equities analysts anticipate that Merit Medical Systems, Inc. will post 3.37 EPS for the current fiscal year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.